Further COVID-19 Updates: Important Information for Primary Care
Interim communication for Auckland clinicians
Symptoms which should trigger consideration of COVID-19 testing
Northern Region Health Coordination Centre (NRHCC) are working with the Ministry of Health to review the current clinical criteria for COVID-19. Data from the current outbreak suggest that ‘typical’ respiratory symptoms are still the most common symptoms reported. Other less common symptoms may also be present, but usually alongside respiratory symptoms.
Currently listed symptoms for COVID-19 are new or worsening cough, sore throat, shortness of breath, sneezing and runny nose (coryza), anosmia (loss of sense of smell) or dysgeusia (altered sense of taste), fever (at least 38˚C). Other less common symptoms currently listed are diarrhoea, headache, myalgia (muscle aches), nausea, vomiting, or confusion/irritability. Abdominal pain is being added to the less common symptom list.
Clinicians across the health sector are asked to remain vigilant to less specific/common symptoms of COVID-19 in anyone with symptoms consistent with an acute viral illness. While many of these symptoms are not specific to COVID-19, please have a low threshold to swab, especially where there is not another more likely diagnosis for the person’s symptoms.
It is not currently recommended that extended lists of COVID-19 symptoms are added to health sector screening questions, as respiratory symptoms are still part of most common presentations and there are substantial implications for the organisation of clinical services; however, please follow local recommendations. Further advice on this will follow.
Managed Isolation and Quarantine Facility Clinical Team contact details
Each of the Managed Isolation and Quarantine Facility facilities has nurse availability onsite 24 hours, and a doctor or nurse practitioner onsite during the day and on-call overnight.
If you have a specific concern about one of your patients who is in a Managed Isolation and Quarantine Facility, you can contact the nurse on duty by calling:
- Duty Nurse Phone: 021 667 256
- Duty Nurse Phone: 021 354 570
If you need to contact the medical team because of an emergency please call the MIQ medical team: 021 552 043
- Duty Nurse Phone: 021 665 743
These numbers will shortly be listed on the COVID-19 Information HealthPathway under Local guidance > Help lines
COVID-19 Testing information sheet
The COVID-19 Testing Information Sheet for the Northern Region has been updated and can be found on the COVID-19 Information Healthpathway under Local Guidance > Patient Information and is also available on the Auckland Regional Public Health Service website here. This information sheet should be provided to people when they have a COVID-19 test.
COVID-19 Vaccinations Update
Supporting patients impacted by a possible dilution error at Highbrook Vaccination Centre on 12 July
As a precaution, all patients who attended the Highbrook Vaccination Centre on 12 July are being offered a third dose of the COVID-19 vaccination due to a possible vaccine dilution error on that day.
Affected patients will be sent a letter today explaining the situation and offering them a third dose.
There are risks and benefits to accepting or declining an additional dose. Please help support affected patients to make their decision. A set of frequently asked questions (FAQs) for clinicians have been developed to assist you.
An in-person informed consent discussion will need to occur – both you and your patient need to sign the attached consent form. You will also need to complete a prescription.
The letter, the FAQs, consent form, prescription template and a quick step guide are attached and will be available shortly on the COVID-19 Vaccination Information HealthPathway.
The patient will need to take both the consent form and the prescription with them to their vaccination appointment.
IMAC is available to support you with clinical questions on 0800 466 863.
Extension 3rd Dose Vaccine - Quick Step Guide.pdf [734.7 KB]
Highbrook Clinician FAQ090921.pdf [605.4 KB]
Highbrook consumer consent_final090921.pdf [727.7 KB]
Highbrook consumer letter_090921.pdf [592.5 KB]
COVID-19 Vaccine Rx.pdf [1.4 MB]
To send feedback, please reply to this email, or email Stuart.firstname.lastname@example.org.